Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
- Conditions
- GlioblastomaBrain Cancer
- Registration Number
- NCT02375841
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. Ultimately, the investigators hope to use these findings to improve communication between patients, caregivers and their doctors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 309
Patient Inclusion Criteria:
- 18 years or older
- Pathologic diagnosis of WHO grade IV glioma, as per MSKCC medical record or outside medical record.
- In the judgment of the consenting professional, proficiency in English that will allow the participant to be able to complete study questionnaires and assessments. Many of the study assessments are available only in English.
- At the time of consent, orientation to self, place, month and year
Caregiver Inclusion Criteria:
- 18 years or older
- Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her informal (unpaid) care (i.e., physical or emotional assistance).
- In the judgment of the consenting professional, proficiency in English that will allow to complete study questionnaires and assessments. Many of the study assessments are available only in English.
Oncologist Inclusion Criteria:
- Treating Neuro-Oncologist in the Department of Neurology
Patient Exclusion Criteria:
- A patient will be excluded if in the opinion of his/her attending neuro-oncologist or the covering neuro-oncologist, he does not have the capacity to consent to the study based on clinical evaluation
- Aphasia precluding comprehension and verbalization of consent to participate, in the estimation of the attending physician.
Caregiver Exclusion Criteria:
- There are no caregiver exclusion criteria.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of responses from caregivers to 3 yes/no questions 2 years The curability of the patient's cancer (curability) The patient's prognosis (prognosis)The patient's goals of care should his/her condition worsen and he/she becomes critically ill (EOL)
number of responses from patients, to 3 yes/no questions 2 years The curability of the patient's cancer (curability) The patient's prognosis (prognosis)The patient's goals of care should his/her condition worsen and he/she becomes critically ill (EOL)
number of responses from physicians to 3 yes/no questions 2 years The curability of the patient's cancer (curability) The patient's prognosis (prognosis)The patient's goals of care should his/her condition worsen and he/she becomes critically ill (EOL)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States
Memorial Sloan Kettering Basking Ridge
🇺🇸Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth
🇺🇸Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen
🇺🇸Montvale, New Jersey, United States
Memorial Sloan Kettering Commack
🇺🇸Commack, New York, United States
Memorial Sloan Kettering Westchester
🇺🇸Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
University of Vermont Medical Center
🇺🇸Burlington, Vermont, United States
Henry Ford Hospital🇺🇸Detroit, Michigan, United States